Prof. LI Chi-kong currently is Research Professor at Department of Paediatrics of The Chinese University of Hong Kong, and honorary consultant at Prince of Wales Hospital and Hong Kong Children’s Hospital. He received his M.B., B.S. at the University of Hong Kong in 1981 and obtained the Doctor of Medicine from CUHK in 2002. He is a specialist in paediatric haematology and oncology. He had been Chief of Service of Department of Paediatrics, Prince of Wales Hospital at Hong Kong from 2004 to 2014. He also served as Chairman of Coordinating Committee in Paediatrics at Hospital Authority from 2010-2015, and also Board Member of Hospital Authority from 2012-2015. He was the past Continental President of Asia of International Society of Pediatric Oncology. Dr. Li is now the Director of Committee of Subspecialty Boards of Hong Kong College of Paediatricians. His research interest is acute lymphoblastic leukaemia (ALL), cellular therapy and thalassaemia. He has been the coordinator of ALL studies in Hong Kong since 1993, and also serves as co-principal investigators of several national ALL studies in China. Internationally he is a member of IBFM Study Group, and have participated in several international clinical trials for subtypes of ALL. He was the founding chairman of Hong Kong Society of Children’s Palliative Care in 2017.   

He also serves in a number of NGOs as Board members or Advisors. He is currently Council member of Hong Kong Red Cross, Panel chair of Public Complaint Committee of Hospital Authority, Board Member of Children’s Thalassaemia Foundation and Hong Kong Marrow Match Foundation. He was awarded Justice of Peace in 2013.